OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
Brittani R. Price, Tiffany L. Sudduth, Erica M. Weekman, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 94
Brittani R. Price, Tiffany L. Sudduth, Erica M. Weekman, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 94
Showing 26-50 of 94 citing articles:
Microglia, Trem2, and Neurodegeneration
Qian Shi, Raul A. Gutierrez, Manzoor A. Bhat
The Neuroscientist (2024)
Open Access | Times Cited: 10
Qian Shi, Raul A. Gutierrez, Manzoor A. Bhat
The Neuroscientist (2024)
Open Access | Times Cited: 10
Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease
Hua Long, Adam Simmons, Arthur J. Mayorga, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Hua Long, Adam Simmons, Arthur J. Mayorga, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis
Ainhoa Etxeberría, Yun‐An A. Shen, Stephen Vito, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 29, pp. e2347232024-e2347232024
Closed Access | Times Cited: 8
Ainhoa Etxeberría, Yun‐An A. Shen, Stephen Vito, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 29, pp. e2347232024-e2347232024
Closed Access | Times Cited: 8
Microglia Diversity in Healthy and Diseased Brain: Insights from Single-Cell Omics
Natalia Ochocka, Bożena Kamińska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3027-3027
Open Access | Times Cited: 53
Natalia Ochocka, Bożena Kamińska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3027-3027
Open Access | Times Cited: 53
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Madeleine R. Brown, Sheena E. Radford, Eric W. Hewitt
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 50
Madeleine R. Brown, Sheena E. Radford, Eric W. Hewitt
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 50
Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Stefan F. Lichtenthaler, Sarah K. Tschirner, Harald Steiner
Current Opinion in Neurobiology (2021) Vol. 72, pp. 101-110
Closed Access | Times Cited: 44
Stefan F. Lichtenthaler, Sarah K. Tschirner, Harald Steiner
Current Opinion in Neurobiology (2021) Vol. 72, pp. 101-110
Closed Access | Times Cited: 44
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
Xavier Morató, Vanesa Pytel, Sara Jofresa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9305-9305
Open Access | Times Cited: 33
Xavier Morató, Vanesa Pytel, Sara Jofresa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9305-9305
Open Access | Times Cited: 33
The Role of Glial Cells in Synaptic Dysfunction: Insights into Alzheimer's Disease Mechanisms
Yang Yu, Ran Chen, Kaiyue Mao, et al.
Aging and Disease (2023) Vol. 15, Iss. 2, pp. 459-459
Open Access | Times Cited: 22
Yang Yu, Ran Chen, Kaiyue Mao, et al.
Aging and Disease (2023) Vol. 15, Iss. 2, pp. 459-459
Open Access | Times Cited: 22
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Bartolo Tamburini, Giusto Davide Badami, Marco Pio La Manna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11922-11922
Open Access | Times Cited: 18
Bartolo Tamburini, Giusto Davide Badami, Marco Pio La Manna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11922-11922
Open Access | Times Cited: 18
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 16
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 16
Targeting Microglia in Alzheimer’s Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules
Ziyad M. Althafar
Molecules (2022) Vol. 27, Iss. 13, pp. 4124-4124
Open Access | Times Cited: 25
Ziyad M. Althafar
Molecules (2022) Vol. 27, Iss. 13, pp. 4124-4124
Open Access | Times Cited: 25
APOE and immunity: Research highlights
Courtney M. Kloske, Christopher J. Barnum, André F. Batista, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 6, pp. 2677-2696
Open Access | Times Cited: 15
Courtney M. Kloske, Christopher J. Barnum, André F. Batista, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 6, pp. 2677-2696
Open Access | Times Cited: 15
Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
Nour S. Tobeh, Kimberley D. Bruce
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 13
Nour S. Tobeh, Kimberley D. Bruce
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 13
Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases
Jannis Wißfeld, Tawfik Abou Assale, Germán Cuevas-Ríos, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Jannis Wißfeld, Tawfik Abou Assale, Germán Cuevas-Ríos, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Decoding sTREM2: its impact on Alzheimer’s disease – a comprehensive review of mechanisms and implications
Cui Lin, Yu Kong, Qian Chen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Cui Lin, Yu Kong, Qian Chen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Targeting Neuroinflammation as Disease Modifying Approach to Alzheimer’s Disease: Potential and Challenges
Smita Jain, Ritu Singh, Sarvesh Paliwal, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 23, Iss. 22, pp. 2097-2116
Closed Access | Times Cited: 12
Smita Jain, Ritu Singh, Sarvesh Paliwal, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 23, Iss. 22, pp. 2097-2116
Closed Access | Times Cited: 12
HEBE: A novel chimeric chronokine for ameliorating memory deficits in Alzheimer’s disease
Jon Esandi, Pedro Renault, Maria Dolores Capilla-López, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117815-117815
Closed Access
Jon Esandi, Pedro Renault, Maria Dolores Capilla-López, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117815-117815
Closed Access
Docking and Molecular Dynamic Simulation of ApoE isoforms to Trem2
Steven Lehrer, Peter H. Rheinstein
Research Square (Research Square) (2025)
Closed Access
Steven Lehrer, Peter H. Rheinstein
Research Square (Research Square) (2025)
Closed Access
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
Geoffrey Canet, Charleine Zussy, Mathieu Vitalis, et al.
British Journal of Pharmacology (2025)
Closed Access
Geoffrey Canet, Charleine Zussy, Mathieu Vitalis, et al.
British Journal of Pharmacology (2025)
Closed Access
Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease
Anne L. Wright, Aldis P. Weible, Olivia B. Estes, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Anne L. Wright, Aldis P. Weible, Olivia B. Estes, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Treadmill exercise ameliorates hippocampal synaptic injury and recognition memory deficits by TREM2 in AD rat model
Linlin Zhang, Pei Liu, Xin Wang, et al.
Brain Research Bulletin (2025) Vol. 223, pp. 111280-111280
Open Access
Linlin Zhang, Pei Liu, Xin Wang, et al.
Brain Research Bulletin (2025) Vol. 223, pp. 111280-111280
Open Access
Infections, Genetics, and Alzheimer's Disease: Exploring the Pathogenic Factors for Innovative Therapies
Ramesh Kordi, T. John Andrews, Mark D. Hicar
Virology (2025), pp. 110523-110523
Closed Access
Ramesh Kordi, T. John Andrews, Mark D. Hicar
Virology (2025), pp. 110523-110523
Closed Access
TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
Lianshuai Zhang, Xianyuan Xiang, Y. Li, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Lianshuai Zhang, Xianyuan Xiang, Y. Li, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice
Peng Zhao, Yuanzhong Xu, Xuejun Fan, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Peng Zhao, Yuanzhong Xu, Xuejun Fan, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 18
p38α‐MAPK‐deficient myeloid cells ameliorate symptoms and pathology of APP ‐transgenic Alzheimer's disease mice
Qinghua Luo, Laura Schnöder, Wenlin Hao, et al.
Aging Cell (2022) Vol. 21, Iss. 8
Open Access | Times Cited: 16
Qinghua Luo, Laura Schnöder, Wenlin Hao, et al.
Aging Cell (2022) Vol. 21, Iss. 8
Open Access | Times Cited: 16
